114 related articles for article (PubMed ID: 8793913)
1. Protective actions of the 5-HT2A/2C receptor agonist, DOI, on 5-HT1A receptor-mediated inhibition of lordosis behavior.
Maswood S; Andrade M; Caldarola-Pastuszka M; Uphouse L
Neuropharmacology; 1996 Apr; 35(4):497-501. PubMed ID: 8793913
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
Uphouse L; Caldarola-Pastuszka M; Moore N
Neuropharmacology; 1993 Jul; 32(7):641-51. PubMed ID: 8361579
[TBL] [Abstract][Full Text] [Related]
4. Agonist activation of 5-HT1A receptors in the median raphe nucleus and female rat lordosis behavior.
Uphouse L; Maswood S; Caldarola-Pastuszka M
Brain Res; 1994 Dec; 668(1-2):271-5. PubMed ID: 7704614
[TBL] [Abstract][Full Text] [Related]
5. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
Selvamani A; Lincoln C; Uphouse L
Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptor antagonists and lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
[TBL] [Abstract][Full Text] [Related]
7. Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior.
Maswood N; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Aug; 802(1-2):98-103. PubMed ID: 9748522
[TBL] [Abstract][Full Text] [Related]
8. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
Uphouse L; Maswood S; Jackson A
Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
[TBL] [Abstract][Full Text] [Related]
9. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.
Wolf A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Jan; 779(1-2):84-95. PubMed ID: 9473601
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
Wolf A; Jackson A; Price T; Trevino A; Caldarola-Pastuszka M; Uphouse L
Brain Res; 1998 Sep; 804(2):206-11. PubMed ID: 9757039
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
[TBL] [Abstract][Full Text] [Related]
13. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior.
Uphouse L; Caldarola-Pastuszka M; Montanez S
Neuropharmacology; 1992 Oct; 31(10):969-81. PubMed ID: 1436391
[TBL] [Abstract][Full Text] [Related]
15. WAY100635 and female rat lordosis behavior.
Uphouse L; Wolf A
Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2C receptor involvement in female rat lordosis behavior.
Wolf A; Caldarola-Pastuszka M; DeLashaw M; Uphouse L
Brain Res; 1999 Apr; 825(1-2):146-51. PubMed ID: 10216181
[TBL] [Abstract][Full Text] [Related]
17. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior.
Uphouse L; White S; Harrison L; Hiegel C; Majumdar D; Guptarak J; Truitt WA
Pharmacol Biochem Behav; 2003 Aug; 76(1):63-73. PubMed ID: 13679218
[TBL] [Abstract][Full Text] [Related]
18. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
Hasegawa Y; Ono H
Brain Res; 1996 Oct; 738(1):158-61. PubMed ID: 8949941
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
20. Female sexual behavior following intracerebral infusion of the 5-HT1A agonist, 8-OH-DPAT, into the medial preoptic area.
Uphouse L; Caldarola-Pastuszka M
Brain Res; 1993 Jan; 601(1-2):203-8. PubMed ID: 8431766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
